Follow
Dina Hany
Dina Hany
Département de Biologie Moléculaire et Cellulaire, Université de Genève, Sciences III, 1211 Genève 4
Verified email at unige.ch
Title
Cited by
Cited by
Year
Hyperactivation of MAPK induces tamoxifen resistance in SPRED2-deficient ERα-positive breast cancer
V Vafeiadou, D Hany, D Picard
Cancers 14 (4), 954, 2022
142022
Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life
K Bhattacharya, S Maiti, S Zahoran, L Weidenauer, D Hany, D Wider, ...
bioRxiv, 2022
102022
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells
D Hany, V Vafeiadou, D Picard
Science Advances 9 (19), eadd3685, 2023
52023
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
GM Ramzy, M Norkin, T Koessler, L Voirol, M Tihy, D Hany, T McKee, ...
Journal of Experimental & Clinical Cancer Research 42 (1), 79, 2023
42023
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
D Hany, M Zoetemelk, K Bhattacharya, P Nowak-Sliwinska, D Picard
Cellular and Molecular Life Sciences 80 (3), 80, 2023
42023
Hsf1 and the molecular chaperone Hsp90 support a ‘rewiring stress response’leading to an adaptive cell size increase in chronic stress
S Maiti, K Bhattacharya, D Wider, D Hany, O Panasenko, L Bernasconi, ...
Elife 12, RP88658, 2023
32023
Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer. Cancers 2022, 14, 954
V Vafeiadou, D Hany, D Picard
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7